Bank Of America Corp Arcus Biosciences, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 140,913 shares of RCUS stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

140,913

Previous 141,522 0.43%

Holding current value

$2.07 Million

Previous $2.16 Million 0.05%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.69 - $18.01 $8,337 - $10,968	-609 Reduced 0.43%	140,913 $2.15 Million
Q2 2024 Aug 14, 2024	SELL	$14.59 - $18.48 $117,157 - $148,394	-8,030 Reduced 5.37%	141,522 $2.16 Million
Q1 2024 May 15, 2024	SELL	$14.83 - $20.18 $227,492 - $309,561	-15,340 Reduced 9.3%	149,552 $2.82 Million
Q4 2023 Feb 14, 2024	SELL	$13.43 - $19.63 $310,622 - $454,022	-23,129 Reduced 12.3%	164,892 $3.15 Million
Q2 2023 Aug 14, 2023	SELL	$16.97 - $22.03 $16.3 Million - $21.2 Million	-961,197 Reduced 83.64%	188,021 $3.82 Million
Q1 2023 May 12, 2023	BUY	$15.96 - $23.15 $16.1 Million - $23.4 Million	1,010,207 Added 726.71%	1,149,218 $21 Million
Q4 2022 Feb 10, 2023	SELL	$19.7 - $35.71 $206,180 - $373,740	-10,466 Reduced 7.0%	139,011 $2.87 Million
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $1.57 Million - $2.03 Million	67,489 Added 82.32%	149,477 $3.91 Million
Q2 2022 Aug 12, 2022	SELL	$17.23 - $37.73 $955,799 - $2.09 Million	-55,473 Reduced 40.36%	81,988 $2.08 Million
Q1 2022 May 16, 2022	BUY	$28.92 - $41.83 $1.16 Million - $1.67 Million	39,989 Added 41.03%	137,461 $4.34 Million
Q4 2021 Feb 08, 2022	BUY	$31.38 - $48.47 $903,806 - $1.4 Million	28,802 Added 41.94%	97,472 $3.95 Million
Q3 2021 Nov 15, 2021	BUY	$26.93 - $37.68 $858,609 - $1.2 Million	31,883 Added 86.67%	68,670 $2.39 Million
Q2 2021 Sep 13, 2021	BUY	$22.75 - $35.77 $836,904 - $1.32 Million	36,787 New	36,787 $1.01 Million

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.7M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.06B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Arcus Biosciences, Inc. Transaction History